Therapeutics (TGTX) 2025 Earnings Outlook for Investors
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Budgeting is crucial for new investors to allocate capital wisely and monitor risk. Learn practical budgeting steps that support investing success.
28,351 articlesTG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Citi, Ford, and Experian unveil scalable AI agent playbooks that emphasize governance and visibility as they push AI ...
OpenAI wins a Pentagon deal to deploy its AI in classified systems as Anthropic is designated a supply chain risk by ...
A top Moody’s economist argues AI-related costs are propping up inflation, not damping it. He warns relief won’t arri...
President Donald Trump escalated tensions with Spain by threatening a broad trade squeeze after Madrid refused to len...
Strategy faces an $8 billion cash wall over the next two years as STRC trades well below par, sharpening questions ab...
Analysts map a long-range path for SoFi Technologies, with a potential move into the upper 40s by 2030 as digital ban...
Apple sticks to an asset-light model with robust buybacks, while Microsoft escalates capital spending to fuel AI and ...
Choosing crypto exposure can feel overwhelming. This guide compares FBTC and ETHA, unpacking costs, risk, and real‑wo...
Inflation is back, and 2026 could test investors in new ways. This guide breaks down what inflation surging: here's t...
Joby Aviation reports modest quarterly revenue gains and robust cash reserves while advancing certification and inter...
What if a straightforward, low-cost index fund could quietly compound into meaningful wealth over three decades? This...